ZAS Corporation Showcases Oncology Expertise at Bangladesh International Cancer Congress 2025
https://www.facebook.com/share/v/14SNNtbVSs7 ZAS Corporation proudly participated in the Bangladesh International Cancer Congress (BICC) 2025, highlighting its oncology and biosimilar portfolio aimed at improving cancer care in Bangladesh. During the congress, the ZAS oncology team engaged with leading medical professionals, sharing practical insights and discussing emerging advancements in cancer treatment. These interactions underscored ZAS’s ongoing commitment to […]


